Quarterly report pursuant to Section 13 or 15(d)

Discontinuing Operations (Tables)

v3.22.2.2
Discontinuing Operations (Tables)
9 Months Ended
Sep. 30, 2022
Discontinued Operations and Disposal Groups [Abstract]  
Schedule of Discontinuing Operations from Income Statement and Balance Sheet

Results of discontinuing operations were as follows for the three and nine months ended September 30, 2022 and 2021:

 

Schedule of Discontinuing Operations from Income Statement and Balance Sheet

    2022     2021     2022     2021  
    Three months ended
September 30,
    Nine months ended
September 30,
 
    2022     2021     2022     2021  
Revenue   $ 2,140     $ 1,251     $ 5,180     $ 2,887  
Cost of goods sold     1,097       952       2,477       1,901  
General and administrative     1,287       1,489       3,428       2,419  
Impairment charge (recovery) of goodwill and intangible assets     (388 )     -       5,415       -  
Total operating costs and expenses     1,996       2,441       11,320       4,320  
Income (loss) from discontinuing operations     144     (1,190 )     (6,140 )     (1,433 )
Total other (expense) income    

-

    3       3       6  
Income (loss) from discontinuing operations before income taxes     144     (1,187 )     (6,137 )     (1,427 )
Income tax benefit     40       -       84       -  
Net income (loss) from discontinuing operations   $ 184   $ (1,187 )   $ (6,053 )   $ (1,427 )

 

 

Assets and liabilities of discontinuing operations were as follows as of September 30, 2022 and December 31, 2021:

 

    September 30, 2022     December 31, 2021  
Accounts receivable   $ 796     $ 457  
Other current assets     326       345  
Assets of discontinuing operations - current     1,122       802  
                 
Fixed assets, net of accumulated depreciation     242       163  
Operating lease right-of-use assets     844       30  
Intangible assets, net     5,511       8,787  
Goodwill     -       2,164  
Other assets     366       364  
Assets of discontinuing operations - non-current     6,963       11,508  
                 
Accounts payable   $ 810     $ 358  
Accrued expense     363       418  
Obligation under operating lease, current     152       29  
Obligation under finance lease, current     30       32  
Deferred revenue     1,935       1,911  
Taxes payable     275       365  
Other current liabilities     280       409  
Liabilities of discontinued operations - current     3,845       3,522  
                 
Obligations under operating leases, less current     709       2  
Obligations under finance leases, less current     19       47  
Liabilities of discontinued operations - non-current     728       49  
Schedule of Intangible Assets

Intangible assets consisted of the following as of September 30, 2022 and December 31, 2021:

 

Schedule of Intangible Assets

    September 30, 2022     December 31, 2021  
Customer relationships   $ 5,241     $ 8,000  
Trade name     983       1,500  
Intangible assets, net     6,224       9,500  
Less accumulated amortization     (713 )     (713 )
Intangible assets, net   $ 5,511     $ 8,787  
Schedule of Goodwill Rollforward

Goodwill arising from the Merger was solely attributed to the vivoPharm business. The following is a roll forward of goodwill as of and for the nine months ended September 30, 2022:

 

Schedule of Goodwill Rollforward

    2022  
       
Beginning balance, January 1   $ 2,164  
Purchase price adjustments     -  
Impairment charge     (2,164 )
Ending balance, September 30   $ -